Spectrum and dosing of urate-lowering drugs in a large cohort of chronic kidney disease patients and their effect on serum urate levels: a cross-sectional analysis from the German Chronic Kidney Disease study

BACKGROUND: Despite a plethora of studies on the effect of urate-lowering therapy (ULT) in patients with chronic kidney disease (CKD), current guidelines on the treatment of hyperuricaemia and gout vary, especially concerning the need for dose adjustment of allopurinol, whose main metabolite is accu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kielstein, Jan T, Heisterkamp, Markus, Jing, Jiaojiao, Nadal, Jennifer, Schmid, Matthias, Kronenberg, Florian, Busch, Martin, Sommerer, Claudia, Lorenzen, Johan M, Eckardt, Kai-Uwe, Köttgen, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857844/
https://www.ncbi.nlm.nih.gov/pubmed/33564429
http://dx.doi.org/10.1093/ckj/sfz136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857844/
https://www.ncbi.nlm.nih.gov/pubmed/33564429
http://dx.doi.org/10.1093/ckj/sfz136

Ejemplares similares